| Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range T Battelino, T Danne, RM Bergenstal, SA Amiel, R Beck, T Biester, E Bosi, ... Diabetes care 42 (8), 1593-1603, 2019 | 3051 | 2019 |
| International consensus on use of continuous glucose monitoring T Danne, R Nimri, T Battelino, RM Bergenstal, KL Close, JH DeVries, ... Diabetes care 40 (12), 1631-1640, 2017 | 1898 | 2017 |
| Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57 DJG Mackay, JLA Callaway, SM Marks, HE White, CL Acerini, SE Boonen, ... Nature genetics 40 (8), 949-951, 2008 | 582 | 2008 |
| Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with … B Karges, A Schwandt, B Heidtmann, O Kordonouri, E Binder, U Schierloh, ... Jama 318 (14), 1358-1366, 2017 | 492 | 2017 |
| Nocturnal glucose control with an artificial pancreas at a diabetes camp M Phillip, T Battelino, E Atlas, O Kordonouri, N Bratina, S Miller, T Biester, ... New England Journal of Medicine 368 (9), 824-833, 2013 | 489 | 2013 |
| Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey O Kordonouri, A Klinghammer, EB Lang, A Grüters-Kieslich, M Grabert, ... Diabetes care 25 (8), 1346-1350, 2002 | 448 | 2002 |
| GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus J Ludvigsson, D Krisky, R Casas, T Battelino, L Castaño, J Greening, ... New England Journal of Medicine 366 (5), 433-442, 2012 | 394 | 2012 |
| Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes … KO Schwab, J Doerfer, W Hecker, J Grulich-Henn, D Wiemann, ... Diabetes care 29 (2), 218-225, 2006 | 316 | 2006 |
| Birth weight and parental BMI predict overweight in children from mothers with gestational diabetes UM Schaefer-Graf, J Pawliczak, D Passow, R Hartmann, R Rossi, ... Diabetes care 28 (7), 1745-1750, 2005 | 314 | 2005 |
| Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty O Kordonouri, R Hartmann, D Deiss, M Wilms, A Grüters-Kieslich Archives of disease in childhood 90 (4), 411-414, 2005 | 249 | 2005 |
| MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial R Nimri, I Muller, E Atlas, S Miller, A Fogel, N Bratina, O Kordonouri, ... Diabetes care 37 (11), 3025-3032, 2014 | 211 | 2014 |
| Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy T Danne, O Kordonouri, M Holder, H Haberland, S Golembowski, ... Diabetes technology & therapeutics 13 (11), 1129-1134, 2011 | 205 | 2011 |
| Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial M Knip, HK Åkerblom, D Becker, HM Dosch, J Dupre, W Fraser, N Howard, ... Jama 311 (22), 2279-2287, 2014 | 200 | 2014 |
| Diabetic retinopathy in type 1 diabetes—a contemporary analysis of 8,784 patients HP Hammes, W Kerner, S Hofer, O Kordonouri, K Raile, RW Holl, ... Diabetologia 54, 1977-1984, 2011 | 185 | 2011 |
| Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries T Danne, T Battelino, P Jarosz-Chobot, O Kordonouri, E Pánkowska, ... Diabetologia 51, 1594-1601, 2008 | 175 | 2008 |
| Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes O Kordonouri, D Deiss, T Danne, A Dorow, C Bassir, A Grüters‐Kieslich Diabetic medicine 19 (6), 518-521, 2002 | 171 | 2002 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 168 | 2023 |
| Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment O Kordonouri, E Pankowska, B Rami, T Kapellen, R Coutant, R Hartmann, ... Diabetologia 53, 2487-2495, 2010 | 166 | 2010 |
| Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial M Knip, HK Åkerblom, E Al Taji, D Becker, J Bruining, L Castano, T Danne, ... Jama 319 (1), 38-48, 2018 | 157 | 2018 |
| “Let the algorithm do the work”: reduction of hypoglycemia using sensor-augmented pump therapy with predictive insulin suspension (SmartGuard) in pediatric type 1 diabetes patients T Biester, O Kordonouri, M Holder, K Remus, D Kieninger-Baum, ... Diabetes technology & therapeutics 19 (3), 173-182, 2017 | 155 | 2017 |
